133 related articles for article (PubMed ID: 7073798)
1. Effect of clinofibrate, a new hypolipidemic agent, on biliary and serum lipids in patients with hyperlipidemia.
Takeuchi N; Kukita H; Kajiyama G; Fujiyama M; Ishikawa K; Miki H; Mishima T; Murata K; Asano T
Atherosclerosis; 1982 Apr; 42(2-3):129-39. PubMed ID: 7073798
[TBL] [Abstract][Full Text] [Related]
2. Clinofibrate therapy raises high-density lipoprotein levels and lowers atherogenic index in diabetes mellitus patients.
Okada S; Miyai Y; Ichiki K; Sato K; Masaki Y; Higuchi T; Ogino Y; Ota Z
J Int Med Res; 1989; 17(6):521-5. PubMed ID: 2628128
[TBL] [Abstract][Full Text] [Related]
3. [Therapy of hyperlipidemia. Clinical experience with clinofibrate].
Avellone G; Di Garbo V; Strano A
Clin Ter; 1989 Apr; 129(1):25-9. PubMed ID: 2525449
[TBL] [Abstract][Full Text] [Related]
4. Biliary lipid composition in heterozygous familial hypercholesterolemia and influence of treatment with probucol.
Tanno N; Oikawa S; Koizumi M; Kotake H; Hirakawa H; Kanazawa Y; Toyota T
Dig Dis Sci; 1994 Jul; 39(7):1586-91. PubMed ID: 8026274
[TBL] [Abstract][Full Text] [Related]
5. Effect of ursodeoxycholic acid on bile supersaturated with cholesterol in patients pretreated with clofibrate.
Kutz K; Schulte A
Z Gastroenterol; 1981 May; 19(5):231-6. PubMed ID: 7257479
[TBL] [Abstract][Full Text] [Related]
6. Effect of gemfibrozil administration on biliary lipid secretion in hyperlipidemic patients. A crossover study with clofibrate.
Mazzella G; Bazzoli F; Villanova N; Simoni P; Festi D; Roda A; Aldini R; Roda E
Scand J Gastroenterol; 1990 Dec; 25(12):1227-34. PubMed ID: 2274744
[TBL] [Abstract][Full Text] [Related]
7. Effects of some hypolipidemic agents on biochemical values and hepatic peroxisomal enzymes in rats: comparison of probucol, CGA, KCD-232, MLM-160, AL-369 and clinofibrate with clofibrate.
Watanabe T; Mitsukawa M; Horie S; Suga T; Seki K
J Pharmacobiodyn; 1987 Mar; 10(3):142-7. PubMed ID: 3625448
[TBL] [Abstract][Full Text] [Related]
8. Effect of ciprofibrate treatment on biliary lipids in patients with hyperlipoproteinaemia.
Angelin B; Einarsson K; Leijd B
Eur J Clin Invest; 1984 Feb; 14(1):73-8. PubMed ID: 6421601
[TBL] [Abstract][Full Text] [Related]
9. Biliary lipids, lithogenic index and biliary drug concentrations during etofibrate and bezafibrate treatment.
Raedsch R; Plachky J; Wolf N; Simonis G
Eur J Drug Metab Pharmacokinet; 1995; 20(2):113-8. PubMed ID: 8582435
[TBL] [Abstract][Full Text] [Related]
10. Biliary lipid composition during treatment with different hypolipidaemic drugs.
Angelin B; Einarsson K; Leijd B
Eur J Clin Invest; 1979 Jun; 9(3):185-90. PubMed ID: 113218
[TBL] [Abstract][Full Text] [Related]
11. Biliary lipid secretion in patients with heterozygous familial hypercholesterolemia and combined hyperlipidemia. Influence of bezafibrate and fenofibrate.
Leiss O; Meyer-Krahmer K; von Bergmann K
J Lipid Res; 1986 Jul; 27(7):713-23. PubMed ID: 3760707
[TBL] [Abstract][Full Text] [Related]
12. The effects of tiadenol, clofibrate and clofibride on bile composition in the rat.
Rozé C; Cuchet P; Souchard M; Vaille C; Debray C
Eur J Pharmacol; 1977 May; 43(1):57-64. PubMed ID: 862664
[TBL] [Abstract][Full Text] [Related]
13. Effects of cerivastatin sodium, a new HMG-CoA reductase inhibitor, on biliary lipid metabolism in patients with hypercholesterolemia.
Tazuma S; Yamashita G; Ochi H; Miura H; Kajihara T; Hattori Y; Miyake H; Nishioka T; Hyogo H; Sunami Y; Yasumiba S; Kajiyama G
Clin Ther; 1998; 20(3):477-85. PubMed ID: 9663363
[TBL] [Abstract][Full Text] [Related]
14. Action of tiadenol and clofibrate on biliary excretions of cholesterol and bile salts in rats.
Fredj G; Clenet M; Cuchet P; Rousselet F; Rozé C
Digestion; 1979; 19(4):228-36. PubMed ID: 478204
[TBL] [Abstract][Full Text] [Related]
15. Reversal of clofibrate-induced cholesterol oversaturation of bile with chenodeoxycholic acid.
Bateson MC; Ross PE; Murison J; Bouchier IA
Br Med J; 1978 May; 1(6121):1171-3. PubMed ID: 638677
[TBL] [Abstract][Full Text] [Related]
16. [Relation between serum lipoprotein metabolism and biliary lipid metabolism].
Leiss O; von Bergmann K
Klin Wochenschr; 1983 Jun; 61(12):579-92. PubMed ID: 6876687
[TBL] [Abstract][Full Text] [Related]
17. Effect of 3-hydroxy-3-methylglutaric acid administration on bile lipid composition in humans.
Di Padova C; Di Padova F; Buzzetti M; Tritapepe R
Scand J Gastroenterol; 1984 Sep; 19(6):820-3. PubMed ID: 6083597
[TBL] [Abstract][Full Text] [Related]
18. Effects of fenofibrate on biliary lipids and bile acid pool size in patients with type IV hyperlipoproteinemia.
Podda M; Zuin M
Atherosclerosis; 1985 May; 55(2):135-42. PubMed ID: 4004987
[TBL] [Abstract][Full Text] [Related]
19. Effects of clofibrate and of an estrogen-progestin combination on fasting biliary lipids and cholic acid kinetics in man.
Pertsemlidis D; Panveliwalla D; Ahrens EH
Gastroenterology; 1974 Apr; 66(4):565-73. PubMed ID: 4821079
[TBL] [Abstract][Full Text] [Related]
20. Effect of treatment with a bile-sequestering agent (Secholex) on intestinal absorption, duodenal bile acids, and plasma lipids.
Ritland S; Fausa O; Gjone E; Blomhoff JP; Skrede S; Lanner A
Scand J Gastroenterol; 1975; 10(8):791-800. PubMed ID: 173015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
